Board meetings, strategic plans, and buyer signals from Susannah Cohen’s organization
Sep 24, 2026·BoardMeeting
Board
Carcinogen Identification Committee Meeting
The committee meeting focused on the consideration of N-Methyl-N-Formylhydrazine for potential listing as a carcinogen under Proposition 65. Discussions included an extensive review of evidence regarding its carcinogenicity, specifically highlighting data from various animal studies. Additionally, the committee received presentations concerning toxicological findings, pharmacokinetics, metabolism, and structural activity relationships. The session also covered procedural guidelines for public comment and the legal requirements governing the meeting.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Biomonitoring California Scientific Guidance Panel Scientific Guidance Panel Meeting
The meeting included updates on the program's surveillance activities, specifically the CARE study, SEP, Biomsphere, and the Chairs LA study. Key topics discussed included the use of biomonitoring data in chemical risk assessment and management, the analysis of participant feedback on results return materials, and the investigation into community health and air quality impacts resulting from refinery retirements. The panel also reviewed updates on laboratory activities, such as method validation, arsenic speciation, and peer-to-peer lab exchanges, as well as outreach efforts to communicate chemical exposure information and reduction strategies to the public and scientific community.
Jun 5, 2026·BoardMeeting
Board
Office Of Environmental Health Hazard Assessment Public Workshop
The public workshop focused on the development of draft inhalation unit risk factors for acrolein and ethylene oxide. The meeting included presentations on the agency's methodology for determining cancer health guidance values, the role of age sensitivity factors for children, and the process for reviewing and adopting these values. Additional topics included the sources and health impacts of acrolein, specifically relating to community concerns near industrial and oil and gas facilities, and the classification of acrolein as a probable human carcinogen.
Mar 4, 2026·BoardMeeting
Board
Biomonitoring California Scientific Guidance Panel Scientific Guidance Panel Meeting
The meeting featured an overview of the Biomonitoring California program, covering community-focused studies such as ACE, Biosphere, and the CHaRS LA study. Key discussion topics included the analysis of persistent organic pollutant levels in California, participant enrollment and sample collection updates, and results from recent respiratory and exposure studies. The panel evaluated new sample collection methods, specifically micro-sampling devices, and discussed the implementation of an electronic platform for the return of participant results. Additionally, updates on laboratory methods, surveillance study progress, and planning for future surveillance efforts were presented.
Extracted from official board minutes, strategic plans, and video transcripts.
